BrainsWay Ltd. (BWAY)
TASE
Closed
Aug 25, 2026
Day's Range
4,220.0052 wk Range
2,391.00Profile - BWAY - BrainsWay Ltd.
Profile
Mic Code
XTAE
Sector
Healthcare
Industry
Medical Devices
Employees
129
BrainsWay Ltd. is a healthcare company at the forefront of developing advanced medical technology for the treatment of brain health disorders. Specializing in Deep Transcranial Magnetic Stimulation (Deep TMS), BrainsWay aims to offer effective, non-invasive treatment options for conditions such as depression, obsessive-compulsive disorder, and smoking addiction. The firm's cutting-edge Deep TMS systems are designed to stimulate brain regions associated with various mental health conditions, thereby providing patients with alternative therapeutic solutions that differ from traditional pharmaceutical interventions. BrainsWay's technological expertise prominently impacts the mental health sector by expanding treatment options available to practitioners and patients, potentially improving outcomes and quality of life. The company's focus on research and innovation drives its prominent role in the medical devices industry, supporting clinicians across numerous medical centers worldwide. With its innovative spirit, BrainsWay contributes significantly to the evolving landscape of neurotherapeutic solutions, establishing itself as an influential player in the global healthcare market.
Profile Details
Type
Common Stock
Address
16 Hartum St
City
Jerusalem
Zip
9777516
Country
Israel
Phone
972 2 582 4030
Key Executives - BWAY - BrainsWay Ltd.
Key executives
Cross Listings - BWAY - BrainsWay Ltd.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
